Clinical study on relationship of hs-CRP level with presence and prognosis of cardiac dysfunction in patients with type 2 diabetes after percutaneous coronary intervention
Abstract:Objective To investigate the relationship of high-sensitivity C-reactive protein (hs-CRP) level with cardiac dysfunction in patients with type 2 diabetes after percutaneous coronary interventions (PCI) for coronary heart disease (CHD) and its prognostic value.Methods 120 patients who suffered from cardiac dysfunction with type 2 diabetes after PCI for CHD were included in this study, and another 42 healthy people getting check-ups were selected as control group. Clinical baseline levels for blood lipids, hs-CRP, BNP and echocardiography were obtained.Follow-ups of main adverse cardiovascular and cerebrovascular events(MACCE) including death, myocardial infarction, stroke and repeated revascularization were done for 12 months. Data analysis using SPSS statistical software was conducted. Results Patients with cardiac dysfunction were divided into three groups by NYHA heart function classification, including Group C(class Ⅰ and Ⅱ), Group D(class Ⅲ), Group E (class Ⅳ), The levels of hs-CRP, BNP, left ventricular end diastolic volume (LVEDV) and left ventricular end systolic volume (LVESV) in all these three groups were obviously higher than those in the control group, and along with the increase of heart function classification, the levels increased; there was statistically significant difference (P<0.05). The left ventricular ejection fraction (LVEF) levels were obviously higher than that in the control group, and decreased with the increase of heart function classification; the difference was statistically significant (P<0.05). Linear regression analysis showed positive correlation between hs-CRP and BNP,(r=0.52, P<0.05)and negative correlation between hs-CRP and LVEF, (r=(0.67, P<0.05) ;hs-CRP was independent of LVEDV and LVESV; there was positive correlation between BNP and LVEDV,LVESV, (r=0.42, P<0.05; r=0.39, P<0.05, respectively) , and negative correlation with LVEF, (r=-0.78,P<0.05). BNP was superior to hs-CRP in the evaluation and diagnosis of heart failure.Further multivariate logistic regression analysis after grouping according to the occurrence of MACEE showed that both hs-CRP and BNP were independent risk factors of MACEE(P<0.05). Conclusion hs-CRP is independent predictor for cardiac dysfunction. It can effectively help assess the present risk and prognosis of cardiac dysfunction, and has great clinical value in detecting and evaluating cardiovascular diseases.
高乃姝, 郑燕蓉, 郑凤芝, 邓文军, 朱晓雪, 张颖. PCI术后2型糖尿病合并冠心病患者心功能分级与hs-CRP水平及预后的相关性研究[J]. 武警医学, 2015, 26(9): 884-887.
GAO Naishu,ZHENG Yanrong,ZHENG Fengzhi,DENG Wenjun,ZHU Xiaoxue, ZHANG Ying. Clinical study on relationship of hs-CRP level with presence and prognosis of cardiac dysfunction in patients with type 2 diabetes after percutaneous coronary intervention. Med. J. Chin. Peop. Armed Poli. Forc., 2015, 26(9): 884-887.
Wang Y, Wang X, Lau W B, et al. Adiponectin Inhibits Tumor Necrosis Factor-alpha-Induced Vascular Inflammatory Response via Caveolin-Mediated Ceramidase Recruitment and Activation[J]. Circ Res, 2014,114(5):792-805.
[2]
Wang Y, Wang X, Lau W B, et al. Adiponectin Inhibits Tumor Necrosis Factor-alpha-Induced Vascular Inflammatory Response via Caveolin-Mediated Ceramidase Recruitment and Activation[J]. Circ Res, 2014,114(5):792-805.
Li X, Chen C, Gan F. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study[J]. Bmc Cardiovasc Disord, 2014,14:67.
[11]
Li X, Chen C, Gan F. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study[J]. Bmc Cardiovasc Disord, 2014,14:67.
[12]
Babaei M, Dashti N, Lamei N, et al. Evaluation of plasma concentrations of homocysteine, IL-6, TNF-alpha, hs-CRP, and total antioxidant capacity in patients with end-stage renal failure[J]. Acta Med Iran, 2014,52(12):893-898.
[12]
Babaei M, Dashti N, Lamei N, et al. Evaluation of plasma concentrations of homocysteine, IL-6, TNF-alpha, hs-CRP, and total antioxidant capacity in patients with end-stage renal failure[J]. Acta Med Iran, 2014,52(12):893-898.